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 Abstract 
Transfer RNA (tRNA) is a key molecule used for protein synthesis, with multiple 
points of stress-induced regulation that can include transcription, transcript processing, 
localization and ribonucleoside base modification.  Enzyme-catalyzed modification of 
tRNA occurs at a number of base and sugar positions and has the potential to influence 
specific anticodon-codon interactions and regulate translation. Notably, altered tRNA 
modification has been linked to mitochondrial diseases and cancer progression.  In this 
review specific to Eukaryotic systems, we discuss how recent systems-level analyses 
using a bioanalytical platform have revealed that there is extensive reprogramming of 
tRNA modifications in response to cellular stress and during cell cycle progression.  
Combined with genome-wide codon bias analytics and gene expression studies, a 
model emerges in which stress-induced reprogramming of tRNA drives the translational 
regulation of critical response proteins whose transcripts display a distinct codon bias.  
Termed Modification Tunable Transcripts (MoTTs),1 we define them as (1) transcripts 
that use specific degenerate codons and codon biases to encode critical stress response 
proteins, and (2) transcripts whose translation is influenced by changes in wobble base 
tRNA modification.  In this review we note that the MoTTs translational model is also 
applicable to the process of stop-codon recoding for selenocysteine incorporation, as 
stop-codon recoding involves a selective codon bias and modified tRNA to decode 
selenocysteine during the translation of a key subset of oxidative stress response 
proteins.  Further, we discuss how in addition to RNA modification analytics, the 
comprehensive characterization of translational regulation of specific transcripts requires 
a variety of tools, including high coverage codon-reporters, ribosome profiling and linked 
genomic and proteomics approaches. Together these tools will yield important new 
insights into the role of translational elongation in cell stress response. 
 1. Introduction 
The central dogma of molecular biology highlights a unique role for transfer RNA 
(tRNA), one that bridges nucleobase sequence with amino acid sequence during protein 
synthesis. tRNA molecules can range in length from 73 to 94 nucleotides, and there are 
over 25 different enzymatically modified tRNA bases per organism.2 tRNA plays a vital 
role in translation, highlighted by the fact that sequence variants, specific modifications 
and defects in modification systems can be linked to human diseases.3-6 Recent 
evidence provides strong support for the idea that cells use tRNA to dynamically 
regulate gene expression in response to stress.1, 7-12 In this review, we highlight the roles 
that tRNA modification systems play in disease pathologies and in response to 
environmental insults.  Further, we describe how specific transcripts with a distinct codon 
bias encode critical stress response proteins that can be translationally regulated by 
dynamic changes in tRNA wobble base modifications.  We also describe how mass 
spectrometry and computational approaches, combined with molecular analyses, yield 
data that support the idea that critical stress response transcripts have codon biases that 
can be translationally linked to specific tRNA modifications.  Further, these studies lead 
us to propose that reprogrammed tRNAs are involved in the selective translation of 
proteins from families of genes in which there is a second genetic code, in the form of a 
biased use of degenerate codons.   
Our model finds strong parallels in the link between wobble base modifications 
and the use of the non-standard amino acid selenocysteine. Selenocysteine decoding is 
unconventional because it does not have a dedicated triplet codon, and instead 
"recodes" internal UGA stop codons in mRNA. Stop codon recoding depends upon the 
presence of a selenocysteine insertion sequence (SECIS) in the 3’ untranslated region 
(UTR) of the mRNA transcript as well as accessory factors to promote positioning of 
 tRNASEC into the ribosome.13-15 Importantly tRNASEC must contain modified uridine 
wobble bases at position 34 that include 5-methoxycarbonylmethyluridine (mcm5U) and 
5-methoxycarbonylmethyl-2′-O-methyluridine (mcm5Um), which promote optimal 
anticodon-codon interactions needed to decode selenocysteine-containing proteins.16-18 
Stop-codon recoding illustrates our model of codon bias regulating translation, as 
the transcripts that encode the 25 selenoproteins in humans have at least twice as many 
stop codons as the other ~25,000 open reading frames in the genome. Selenoproteins 
also encode critical stress response proteins, namely glutathione peroxidases (GPXs) 
and thioredoxin reductases (TrxRs),15 with GPXs and TrxRs being vital to the 
detoxification of reactive oxygen species (ROS), and TrxRs being further implicated in 
regulating DNA damage responses. Lastly, efficient stop-codon recoding requires 
specifically modified tRNA wobble bases.   Thus, there are established and emerging 
links between tRNA modifications, codon bias, and translational regulation in stress 
responses.  As we continue to characterize dynamic tRNA modification signatures and 
classify gene subsets with an inherent codon bias, our future challenge will be to further 
develop these observations into models of translational regulation that will likely be 
disease-, stress-, toxicant- and cell-specific. This will require large-scale genomics, 
proteomics and computational approaches, as discussed in the final section of this 
review. 
 
2. tRNA  
a) tRNA structure and modification.  The regulatory potential for tRNA modifications 
can be understood in relation to tRNA structure. tRNA is initially transcribed by RNA 
polymerase III (RNA Pol III) using the canonical adenine (A), uracil (U), cytosine (C) and 
 guanine (G) nucleobases in RNA.  tRNA then folds into a four stem clover leaf 
secondary structure as defined by a D-stem and loop (DSL),  T-stem and loop (TSL), 
anticodon stem and loop (ASL) and  aminoacylation stem, and in some cases a fifth 
stem in the form of a variable loop.19, 20 The DSL and TSL contain the modified 
nucleotides dihydrouridine (D) and pseudouridine (ψ), respectively, but highlight the fact 
that many different tRNA nucleotides can be enzymatically modified post-
transcriptionally.  There are over 120 known post-transcriptional tRNA modifications that 
provide structural stability and help in decoding, among many other known and potential 
functions.19, 20 The aminoacylation stem contains a single-stranded 5’-CAA-3’ tail that is 
enzymatically charged with specific amino acids, with the associated aminoacyl tRNA 
synthetase (aaRS) enzymes well described in another review.21  The ASL contains the 
three-nucleotide anticodon sequence at positions 34 to 36, which will base pair with 
mRNA codons during translation.  Positions 34 and 37 on tRNA can be enzymatically 
modified to influence binding of the tRNA molecule to the mRNA codon, with 
modifications including mcm5U34, 5-methylcytidine (m5C34), N6-
threonylcarbamoyladenosine (t6A37) and N6-isopentenyladenosine (i6A37), (Figure 1), to 
name just a few.2 Notably other modification chemistries within the anti-codon stem loop 
structure and throughout tRNA can also influence anticodon-codon interactions and alter 
the decoding capacity of the tRNA molecule.22 
 
b) tRNA function, codons and mistranslation. To better understand the role of tRNA 
modifications and mRNA codon bias in translational regulation, it is important to review 
aspects of protein synthesis and mistranslation relative to tRNA and codons. The 
recognized genetic code has 64 different three-base combinations that comprise 
codons.  The 61 codons that specify the 20 amino acids are considered to be 
 degenerate, with significant regulatory potential in the multiplicity of codons for each 
amino acid.  For example, there are six degenerate codons for arginine and two for 
glutamic acid; therefore, gene transcripts have multiple codon options for the decoding 
of these two particular amino acids.11, 24, 25 The six codons for arginine are CGU, CGC, 
CGA, CGG, AGA and AGG, with the last two residing in a split codon box with the AGU 
and AGC codons for serine.  The arginine and serine codons found in the split codon 
box only differ by their wobble bases, and paired with malfunctions in protein synthesis 
machinery highlight a potential for arginine to be misincorporated for serine and vice 
versa.   Notably, deficiencies in specific wobble base tRNA modifications (e.g., 
mcm5U34) can lead to amino acid incorporation errors due to improper pairing of 
arginine tRNAs with non-cognate serine codons in the ribosome.10 In addition anti-
microbial aminoglycoside antibiotics can also promote protein errors by disrupting the 
protein synthesis machinery.26-28 Translational errors have the potential to lead to mis-
folded or aggregated proteins. The resulting faulty proteins can activate cellular heat 
shock (HSR) and unfolded protein (UPR) responses, both of which have been implicated 
in disease processes.30-34  
 
3. Human diseases linked to tRNA and modification systems 
a) Mitochondrial diseases.  In addition to protein errors, slowed translation can lead to 
pathological outcomes, as demonstrated by the strong links between tRNA 
hypomodification and human disease.  For example, myoclonus epilepsy associated 
with ragged-red fibers (MERRF) and the condition of mitochondrial encephalopathy, 
lactic acidosis, and stroke-like episodes (MELAS) are both mitochondrial 
encephalomyopathies that are caused by mutations in tRNA genes.  A common feature 
 of these mutant tRNAs is their hypomodification due to sequence changes that prevent 
enzyme-catalyzed modification of wobble bases.  Both MERRF and MELAS are 
examples of diseases in which the pathology can be attributed to defective codon-
anticodon interactions and decreased translation.3, 4 Both MERRF and MELAS share 
common symptoms reflecting similar pathophysiological mechanisms, including lactic 
acidosis, muscle weakness, seizures and other neurological pathology, and lack of 
physical coordination.4, 35  MERRF can occur due to a mutation that prevents wobble 
base thiolation (s2) in the tRNA-Lys that decodes AAG and AAA codons.  This leads to a 
general decrease in translation of lysine in the mitochondria and an overall decrease in 
protein translation that corrupts mitochondrial function.  
 There are two classes of gene defects known to be etiologic for MELAS: 1) 
mutations in mitochondrial-specific genes that encode the complex I enzymes that 
operate the electron transport chain, and 2) mutations in mitochondrial-specific tRNA 
genes encoding leucine, histidine and valine isoacceptors; all cause a decrease in the 
levels of essential mitochondrial enzymes used to synthesize ATP.36  For example, the 
wobble uridine of mitochondrial tRNALeu decodes UUG codons and is modified to 5-
taurinomethyluridine (tm5U) using the β-amino acid taurine as a cofactor. MELAS arises 
when a mutation in tRNALeu prevents modification to tm5U34.37 Furthermore, taurine 
deficiency can lead to hypomodified tRNAs, and promote a decrease in the translation of 
the UUG-rich transcript encoding the mitochondrial complex I protein, ND6, and 
promotes the onset of MELAS.  Thus, taurine deficiency provides a clear mechanistic 
link between modified wobble uridines, codon-specific translation of a key protein, and 
the pathophysiology of a disease.36, 38   
b) tRNA modification and cancer.   tRNA hypomodification is associated with some 
cancers, with a decrease in the levels of the modified nucleoside queuosine (Q) 
 identified in ovarian and blood cancers.39, 40 Decreased Q is further associated with 
higher tumor grades and a poor differentiation status,41 which implicates a growth 
inhibitory role for this wobble base modification. Tumor growth suppressive roles have 
been reported for the confirmed and potential tRNA modification enzymes tRNA-
isopentenyltransferase (tRNA-IPT) and the human tRNA methyltrasferase 9-like protein 
(hTRM9L), respectively.  tRNA-IPT catalyzes the addition of i6A on position 37 in tRNA 
(Figure 1) and decreased levels have been reported in lung adenocarcinomas.5 
Increased expression of full-length tRNA-IPT in A549 lung cancer cells leads to 
decreased proliferation in colony formation assays.5, 6 Similarly, human TRM9L 
(hTRM9L), which is a homolog of the wobble base mcm5U-forming tRNA 
methyltransferase 9 from budding yeast (Figure 1), has been demonstrated to be 
significantly decreased in colorectal, breast and bladder cancers.8 Re-expression of 
hTRM9L in SW620 and HCT116 colorectal lines decreased tumor sizes in xenograft 
models and assessment of hTRM9L levels could be a useful cancer diagnostic.8  
Increased protein translation is linked to cell proliferation in many forms of 
cancer, with cancer-causing mutations affecting translation at several levels.  For 
example, approximately half of all human cancers contain mutations of the p53 gene, 
most notably those of the breast, colon, brain, blood, lung and liver.42 p53 is a negative 
regulator of RNA Pol III transcripts and thus tRNA gene transcription.  In one of the most 
common p53 mutations, R175H, RNA Pol III is activated by the mutated protein, which 
has the effect of increasing the levels of tRNA, sRNA and rRNA43, and, in theory, 
enhancing protein synthesis in the cell.  
At the level of translation, ALKBH8, the other human homolog of S. cerevisiae 
Trm9, and the confirmed wobble base mcm5U tRNA methyltransferase from humans,18 
has been demonstrated to be required for the survival of some bladder cancer cell lines. 
 As evidence, knockdown of ALKBH8 in bladder cancer cell models increases apoptosis, 
and severely limits metastatic potential.44 Given that ALKBH8-catalyzed mcm5U-based 
modifications are important for ROS detoxification, these finding suggest that some 
cancer cells may become “addicted” to specific tRNA modifications as a means of 
adapting to the inherently ROS-rich environment of cancer cells.44-45  In theory this could 
be a hypermodification of tRNA promoting a disease state, but that is speculative at this 
point and requires analytical studies in bladder cancer systems.  Overall, the regulatory 
control, tumor growth suppression and oncogenic like connections between p53, protein 
synthesis and tRNA modification systems is further evidence of the important yet 
complex roles for tRNA and its modifications in cancer pathophysiology.  
Considered together, the above described mitochondrial diseases and different 
cancers demonstrate that defects in tRNA regulation, the integrity of tRNA and 
modification status are linked to pathological outcomes. We and others have observed 
that controlled alteration of tRNA modifications in the anticodon can influence codon 
interactions in ways that affect positive outcomes in terms of normal cell response to 
environmental changes.11, 25, 46 We have proposed the idea that stress-induced 
modifications are partnered with specific degenerate codons in certain transcripts, which 
appears as a codon bias, with both being used to regulate translation.  These concepts 
will be discussed in further detail in following sections. Importantly, deciphering some of 
the rules behind this second genetic code is described further below and has lead to 
insights into regulatory aspects of gene expression. As many diseases are connected to 
stress-induced changes in signaling, understanding the regulation of tRNA as well as the 
regulatory potential of tRNA modifications could lead to diagnostic and therapeutic 
breakthroughs.   
 
 4.  Stress-induced regulation of tRNA  
 The pathway of tRNA biogenesis from gene to precursor tRNA (pre-tRNA) and 
on to a mature tRNA molecule for use in translation is a complex process that begins 
with RNA Pol III directed transcription, followed by 5' and 3' primary transcript 
processing, intron splicing, and, in the case of eukaryotes, export to the cytoplasm for 
aminoacylation.47, 48 The ribonucleosides that comprise the mature tRNA molecule are 
also extensively modified by enzymatic processes to form 20 - 25 different chemically 
altered ribonucleosides in every organism. The biosynthesis of many tRNA modifications 
has been defined for S. cerevisiae, with homologs of the corresponding enzyme systems 
present in humans.49  Biological pathways as complex as those associated with tRNA 
metabolism allow for the regulation of tRNA and modifications at many discrete levels in 
order to fine tune translation, particularly under conditions of stress.  Indeed, there are 
documented cases of stress-induced regulation of tRNA from the initial transcript to 
translation-associated forms (Figure 2), and in this section we will address them and 
pay special attention to the re-programming of modified ribonucleosides in tRNA that 
occurs during replicative and oxidative stresses, as this represents a new and 
burgeoning area of RNA research.  
a) tRNA transcription and transcript processing can be regulated by stress.  tRNA 
transcription is performed by RNA Pol III in coordination with Maf1, a key regulatory 
protein whose activity towards RNA Pol III is heavily influenced by cellular stress 
factors.50 Several studies in S. cerevisiae have shown that under favorable cell growth 
conditions, Maf1 is phosphorylated by nutrient sensing and growth promoting kinases, 
and this phosphorylation reverses the normal inhibitory interaction of Maf1 with RNA Pol 
III.51-55  Conversely, under conditions of stress such as DNA damage and nutrient 
deprivation, Maf1 remains in a non-phosphorylated form that inhibits RNA Pol III-
 dependent transcription.56-60  Additionally, in human glioblastoma cells, Maf1 can 
negatively regulate Pol I- (rRNA) and Pol II- (mRNA) dependent transcription, a function 
that is linked to the transformed state of the cell, and likely evolved to coordinate all 
aspects of protein expression with the cellular milieu.61  
 In almost all domains of life, initial pre-tRNA transcripts undergo processing at 
their 5' and 3' ends before adopting the canonical cloverleaf secondary structure. 
Processing at the 5' end involves the removal of a 5' "leader" sequence by an RNase P 
endonuclease complex, while mature 3' ends are generated by RNase Z-mediated 
endonuclease activity, combined with other exonuclease activities that remove precursor 
"trailer" sequences until the proper 3' end is generated; in some cases, the invariant C 
and/or A terminal nucleotides are added by a tRNA nucleotidyl transferase.63-64 For most 
pre-tRNA molecules, 5' end processing precedes 3' end processing, but the temporal 
nature of this process is not completely understood.63 In eukaryotes, it may be facilitated 
by the molecular chaperone protein La, which binds to 3' oligo-U tracks, providing 
stability to the pre-tRNA molecule, and offering protection to the 3' ends from 
exonuclease activity.63-64  Human La is regulated in a manner similar to that of Maf1 in S. 
cerevisiae: under nutrient-rich conditions, La is phosphorylated by a nutrient-sensing 
kinase, and this phosphorylated form (pLa) binds and stimulates RNase P activity for 
tRNA biogenesis.65, 66 Conversely, in various mammalian thymocyte and cancer-derived 
cells, pLa is dephosphorylated by a protein phosphatase 2A-like activity in cells exposed 
to various forms of DNA damage as well as the death receptor activator, Fas,67 
representing a mechanism for the suppression of tRNA biogenesis under conditions of 
stress leading to apoptosis. 
 Certain subsets of pre-tRNA species also contain introns that typically disrupt the 
anticodon loop, and these intron sequences are removed by an endonuclease-mediated 
 splicing process.68 In Eukarya, the splicing endonuclease is comprised of Sen proteins 
and, although there is no evidence to suggest that these proteins are directly regulated 
by stress per se, point mutations in several human Sen family members are associated 
with the neurodegenerative disease, pontocerebellar hypoplasia (e.g., Sen2, Sen34 and 
Sen54).69  Considering that neuronal dysfunction is tightly linked to free radical 
damage,70, 71 this raises the intriguing possibility that tRNA intron splicing may be 
influenced by oxidative stress in the brain, as is observed with tRNA modifications in 
response to oxidative stress in other eukaryotic and vertebrate cell systems.11, 12, 72, 73 
b) tRNA aminoacylation and localization are regulated by reactive oxygen species.  
During tRNA aminoacylation, individual amino acids are attached to their associated 
tRNAs in a process that involves aminoacyl-tRNA synthetase (aaRS)- catalysis together 
with activation of the amino acid carboxyl group for peptide bond formation.  It is 
important to note that translational fidelity is determined not only by tRNA anticodon 
recognition of the correct cognate codon, but also by attachment of the correct amino 
acid to its corresponding tRNA species.  This specificity is achieved by the catalytic 
active site of the aaRS that typically accommodates only one amino acid for each of the 
appropriate codons,74 and mischarging events are circumvented by the editing function 
of the aaRS.  However, there are low-fidelity strains of S. cerevisiae that exhibit high 
levels of mischarged tRNAs, and this mutant-protein phenotype has been suggested to 
increase survival after stress as a form of "adaptive translation".75 Furthermore, it was 
observed that reactive oxygen species (ROS) stress increases the overall abundance of 
non-methionyl-tRNAs charged with methionine, leading to an overall increase in Met-
misincorporated proteins, and serving to increase the ROS detoxification capacity of the 
cell as a mechanism to protect against oxidative stress-induced damage. 76, 77  
  tRNA biogenic processing events are highly compartmentalized within the cell, 
and this compartmentalization can also be affected by cellular stress.  After 5'-3' 
processing in the nucleus, tRNA molecules are transported to the cytoplasm by export 
proteins belonging to the importin/karyopherin beta superfamily (S. cerevisiae Los1, and 
vertebrate Xpo-t) where they undergo splicing and aminoacylation in the cytoplasm. At 
least two DNA damage response (DDR) proteins are linked to the regulation of tRNA 
molecules within this cellular landscape in S. cerevisiae. The kinases Mec1 and Rad53 
can transmit a cytoplasmic localization signal to Los1 leading to the accumulation of 
unspliced intron-containing tRNAs in the nucleus, effectively coupling the G1 checkpoint 
response to a decrease in protein synthesis after exposures that cause DNA damage.78  
c) Modifications limit tRNA turnover.  Overall tRNA levels are determined both by 
rates of RNA Pol III-dependent transcription and by tRNA turnover pathways, with these 
turnover pathways themselves regulated by mechanisms linked to the modification 
status of individual ribonucleosides.  The nuclear pre-tRNA turnover pathway acts on 
diverse pre-tRNA transcripts; however, for S. cerevisiae it is thought to be particularly 
important for maintaining the level of initiator methionine tRNAs (tRNAMet).79  This 
maintenance mechanism involves the Trm 6/61-mediated 1-methyladenosine (m1A) 
modification at position 58 of tRNAMet, which acts to protect the tRNA from 
polyadenylation by the TRAMP complex and subsequent degradation by Rrp6 and the 
3'- nuclear exosome.  In this way, the levels of m1A58-modified tRNAMet can conceivably 
control the overall rate of AUG-initiated mRNA translation. 
 In contrast to the pre-tRNA degradation pathway, the rapid tRNA decay (RTD) 
pathway acts on mature transcripts and involves degradation from the 5' end that is not 
protected by aminoacylation. The RTD pathway primarily targets hypomodified tRNAs, 
which are tRNAs lacking key modifications to protect them from degradation by 5'-
 exonucleases, identified as Rat1 and Xrn1 in S. cerevisiae.80 These protective 
modifications have been identified as 7-methylguanosine (m7G) and 5-methylcytidine 
(m5C), as catalyzed by Trm8 and Trm4, respectively, and these modification systems 
have been implicated in oxidative stress responses, which will be discussed in greater 
detail in the following sections.81-83 Thus, methylation-based tRNA modifications are 
known to protect against stress-induced tRNA cleavage, possibly playing a role in stress 
signaling or allowing certain tRNA species to translate stress-response proteins despite 
a global decrease in translation.84, 85, 87 
 
5.  Stress-induced reprogramming of modifications in global and specific tRNAs 
 The link between hypomodified tRNA and tRNA degradation exemplifies the 
regulatory potential of tRNA modifications.  Further, the editable chemical nature of 
tRNA modifications and their ability to regulate codon-anticodon interactions also makes 
them potential regulators of gene expression at the level of translation elongation.  For 
enzyme-catalyzed tRNA modifications to be used in regulating translation, tRNA 
modifications must have the ability to be “reprogrammed” in response to different stimuli 
and this reprogramming needs to be linked to the decoding capabilities of the tRNA.  
The following sections describe recent advances in tRNA modification analysis, codon 
usage analytics, and gene expression studies that demonstrate the regulatory nature of 
wobble base tRNA modifications and the biased use of degenerate codons in stress 
response genes. 
 
a) Technology for systems-level quantitation of tRNA modifications.  For tRNA 
modifications to be truly regulatory in nature, there must be coordinated changes in their 
 levels in response to a stimulus. This was shown to be the case for the tRNA wobble 
mcm5U and m5C in response to stress.7, 12, (Chan et al., submitted) To assess the 
generality and scope of stress-induced tRNA modification changes, we developed a 
chromatography-coupled mass spectrometry (LC-MS) platform (Figure 3),7 that involves 
(1) RNA isolation and HPLC purification of tRNA, (2) enzymatic hydrolysis to 
ribonucleosides for resolution by reversed-phase HPLC, (3) mass spectrometric 
identification and quantification of each ribonucleoside, and (4) multivariate statistical 
analysis of fold-change data obtained from control and stressed cells.7, 12 With three 
biological replicates, this approach detects relative changes in tRNA modification levels 
as small as 10% with statistical significance.7, 12  This platform was then used to analyze 
changes in the levels of tRNA modifications after arrest of yeast cells in distinct phases 
of the cell cycle and after yeast cells were exposed to equally toxic doses of four 
different toxicants: H2O2, methyl methanesulfonate (MMS), sodium arsenite (NaAsO2), 
and sodium hypochlorite (NaOCl).9, 12  Quantitative analysis of 23 of the 25 tRNA 
modifications in budding yeast revealed unique changes in response to each toxicant 
and dose. Further analysis using a hierarchical clustering program,88 to group data 
demonstrated specific patterns modification patterns are present depending on agent 
and to some extent dose.12 While the patterns of stress-induced changes in tRNA 
modification levels provided significant predictive power, the observation of changes in 
specific wobble modifications provided important clues about the link between tRNA 
reprogramming and selective translation of codon-biased genes in the cell response to 
each different stress. 
 
b) Stress-induced reprogramming of tRNA modifications 
 ROS stress in yeast.  Intracellular ROS come in many forms and can act as 
important redox-altering molecules that signal to pathways regulating growth, hypoxia, 
immune cell recruitment, and cell mobility.89-91 However, any failure of antioxidant 
enzyme systems to keep ROS levels in balance within the boundaries of normal cell 
survival and growth signaling (i.e., after exposure to environmental ROS-inducing 
toxicants) can lead to oxidative stress.  In addition, exposure to agents that cause ROS 
can promote redox imbalances.  tRNA modification systems have been linked to cellular 
ROS stress responses on several levels.  First, 2'-O-methylcytidine (Cm), 5-
methylcytidine (m5C) and N2,N2-dimethylguanosine (m22G) tRNA modifications have 
been shown to increase in S. cerevisiae after exposure to H2O2, but not in response to 
other stress-inducing agents.12 Importantly, unique patterns of tRNA modification 
reprograming can distinguish mechanistically distinct damaging agents,12 which supports 
the idea the tRNA modification patterns can be used as biomarkers of exposure.  
Secondly, strains lacking the enzymes responsible for catalyzing specific H2O2-induced 
modifications (i.e., Trm4 → m5C and Trm1 → m22G) display a cytotoxic hypersensitivity 
to H2O2, implying that these modification systems are important for cell survival after 
ROS stress.12  The connection between tRNA modification systems and surviving 
cellular stress suggested that Trm1 and Trm4 could regulate critical DNA repair or ROS 
mitigation systems. 
 tRNA modifications in the yeast cell cycle and S-phase stress.  Changes in 
tRNA modification patterns have also been noted for physiological programs and after 
DNA replication stress.  Yeast cells cycle through G1, S and G2 phases during normal 
growth and distinct transcriptional reprogramming has been reported for these phases.92 
However, both transcriptional and post-translational regulation of gene expression are 
characteristic of cell cycle progression, suggesting that translational regulation can also 
 be keyed to specific parts of the cell cycle.  The levels of 16 tRNA modifications [ 
pseudouridine (Y), inosine (I), 2'-O-methylguanosine (Gm), 2'-O-methyluridine (Um), 2'-
O-methylcytidine (Cm), 5-methyluridine (m5U), m5C, 3-methylcytidine (m3C), N7-
methylguanosine (m7G), N4-acetylcytidine (ac4C), m22G, wybutosine (yW), N1-
methylinosine (m1I), N1-methyladenosine (m1A), mcm5U, 5-methoxycarbonylmethyl-2-
thiouridine (mcm5s2U)] have been demonstrated to oscillate throughout the cell cycle in 
S. cerevisiae, demonstrating that distinct regulation of tRNA is programmed into cell 
growth.9  In fact, significant decreases in I, m5U, m5C, Cm, m7G, m1I and m1A 
modifications in G1 and G2 phases suggests that certain tRNA species become 
hypomodified as cells transit these phases of the cell cycle, and further suggests that 
they are being turned over since decreases in m1A, m7G and m5C are linked to tRNA 
degradation.48, 79-81 A significant two-fold increase (P < 0.003) in mcm5U modifications 
was observed during S-phase under DNA-damaging conditions (i.e., treatment with 
hydroxyurea, HU),9 which aligns with phenotypic data demonstrating that the 
corresponding tRNA methyltransferase (Trm9) is required to survive DNA-damaging 
agents hydroxyura (HU), MMS and ionizing radiation,9, 12, 25 linking translation to DNA 
damage response.46 
 tRNA modification reprogramming in human cells.  The connection between 
global tRNA reprogramming and stress has also been reported in human cell lines.  
Several lines of tumorigenic colorectal cancer cells, including SW620 and HCT116, do 
not express the yeast Trm9 homolog hTRM9L, most likely due to epigenetic gene 
silencing.8, 93 The latter is consistent with the observation that treatment of SW620 cells 
with 5-deazacytidine promoted expression of hTRM9L and led to a significant decrease 
in tumor size in xenograft models.  Similarly, SW620 and HCT116 cells reengineered to 
express hTRM9L also had a significant decrease in tumor growth as well as resistance 
 to the aminoglycoside antibiotic paromomycin, which kills in part by inducing 
translational errors.8  Expression of hTRM9L in yeast cells lacking native trm9 also had 
reduced sensitivity to killing by paromomycin.10, 94 To assess the effect of TRM9L 
expression on tRNA modifications, LC-MS analysis was performed on SW620 cells 
reengineered to express hTRM9L, with significant changes observed in the levels of 10 
tRNA modifications [ac4C, Cm, Gm, I, i6A, m1A, N2-methylguanosine (m2G), 5,2'-O-
dimethyluridine (m5Um), hydroxywybutosine (OHyW) and t6A].8  Further, when hTRM9L-
expressing SW620 cells were treated with the translational stressing agent, 
paromomycin, the levels of 4 tRNA modifications (ac4C, m1A, mcm5U and t6A) were 
significantly increased relative to untreated cells.8  Taken together, these results support 
the idea that stress can promote reprogramming of tRNA modifications in human cancer 
models. 
c) Trm4 and Trm9 drive codon-biased translation of critical stress response 
proteins.  Two sets of coupled observations point to a mechanistic link between tRNA 
modification reprogramming and stress response in yeast. The observation that 
oxidative stress caused an elevation in the Trm4-dependent m5C was coupled with the 
observation that trm4Δ cells were sensitive to H2O2-induced cytotoxicity, while the S-
phase damaging agents MMS and HU led to elevations in Trm9-dependent mcm5U and 
cells lacking Trm9 were similarly sensitive to killing by MMS and HU.12, 24, 25 (Chen et al, 
submitted) Together these results suggested that specific modifications are vital to the 
cell response to specific stressors by regulating gene expression.9, 12  
The Trm4/m5C connection was specifically linked to an H2O2-stimulated increase 
in the abundance of tRNALEU(CAA) isoacceptors with m5C at the wobble position.  Further, 
protein expression studies linked Trm4, m5C and tRNALEU(CAA) isoacceptors to increased 
translation of transcripts that use UUG to decode leucine.95  Interestingly, one such 
 UUG-enriched transcript encoded the ribosomal protein RPL22A, which was identified 
as a key protein that prevents ROS sensitivity.  The codon-specific relationship between 
UUG and RPL22A also supports the notion that cells may use an alternate ribosome to 
selectively translate proteins required for survival and DNA repair after oxidative stress 
exposure.96, 97 
The Trm9/mcm5U connection to S-phase damage was also shown to be due to 
the increased translation of stress response transcripts that possess a specific codon 
bias. DNA replication in S-phase is limited by the available pool of intracellular 2-
deoxyribonucleotides (dNTPs), which are formed from their ribonucleotide precursors by 
the ribonucleotide reductase (RNR) complex, composed of subunits 1 through 4.98 The 
activity of the RNR complex is tightly linked to the cell cycle, having a high level of 
activity during the transition from G1 to S phase when the demand for dNTPs is 
accordingly high.99-102  The Trm9-catalyzed mcm5U tRNA modification is required for the 
efficient translation of at least two subunits of the RNR complex (i.e., RNR1 and RNR3) 
after exposure to DNA damaging agents, when there is a similarly high demand for 
dNTPs in order to facilitate DNA repair.9, 103 RNR1 and RNR3 transcripts significantly 
over-use one codon from many split codon boxes, with mcm5U specifically linked to the 
AGA codon for arginine.  It should be emphasized that the translational control by Trm9-
catalyzed tRNA modifications is more complicated than simply linking mcm5U to AGA 
codons, as the mcm5U and its thiolated form (mcm5s2U) have been linked to the 
regulation of AGA, AAG, GAA, TTG an GAG codons, with last two being negatively 
regulated by Trm9.9 The broader implication of these Trm9 studies is that tRNA 
modification-based translational control mechanisms can regulate RNR activity during S-
phase damage and that they can be linked to specific codon usage patterns. In addition, 
they suggest that some tRNA modification and codon combinations can restrict 
 translation. Apart from mcm5U, the biological significance of the 14 other tRNA 
modifications that change when cells enter G1 of G2 is yet to be determined,9 but some 
will likely play regulatory roles similar to modified wobble bases. 
 
6. Modification tunable transcripts (MoTTs) 
 Although no codon in the genetic code can specify more than one amino acid, 
the degeneracy of the genetic code means that several codons can specify the same 
amino acid.  Some synonymous codons are used more frequently than others (i.e., 
optimal codons), a fact that argues for an optimal code for translational efficiency and 
accuracy.104  In support of this argument, the biased used of codons has been positively 
correlated with the number of copies of the associated tRNA gene, the number of copies 
of the expressed tRNA isoacceptor and gene expression levels.105-110 It is now apparent 
that biased codon usage occurs at another level and represents a second genetic code. 
Here we discuss the idea of Modification Tunable Transcripts (MoTTs), which are 
distinct types of transcripts that have significantly different codon usage patterns when 
compared to the average transcript (Figure 3 - bottom right panel and Figure 4), with 
changes in tRNA modification regulating MoTT translation.  To understand the idea 
behind MoTTs, it is important to realize that gene codon usage for amino acid decoding 
is not random; certain gene subsets are enriched for one particular degenerate codon 
over another.1, 11, 25 In tables that specify the genetic code, two-fold degenerate codons 
for one amino acid (i.e., arginine AGA & AGG) are found in a split codon box next to 
other two-fold degenerate codons that specify a different amino acid (i.e., serine AGC & 
AGU). The cognate tRNAs for two-fold degenerate codons require modification at the 
wobble position 34 and position 37 in order to discriminate the correct amino acid,19, 111 
 with hypomodification promoting amino acid misincorporation errors (i.e., arginine 
misincorporation for serine).10  Computational studies and gene expression studies 
mechanistically demonstrated that Trm4- and Trm9-catalyzed tRNA modifications 
increase in response to specific stressors in order to stimulate the translation of 
transcripts that are enriched for specific degenerate codons (Figure 4),12, 25, 95  (Chan et 
al, submitted).  In essence, MoTTs have identified one codon from a 2-fold degenerate 
box as the preferred codon, and are predicted to use tRNA modifications to 
translationally regulate the use of one degenerate codon from each of the 12 split boxes 
specific to 10 amino acids. The ability of cells to increase the levels of a specific 
modification in tRNA in response to stress (i.e., m5C after H2O2) allows for the increased 
efficiency of translation of a specific codon linked to the MoTTs code. The increased 
translation of specific codons should not only increase translational fidelity but also 
promote the faster translation of specific codons.  In either case, be it fidelity or speed, 
increased tRNA modification should increase active protein levels, which in the case of 
stress response proteins allows for a rapid response to damage.  In our model (Figure 
4) of translational regulation of MoTTs by tRNA modifications, increased levels of 
specific modifications in the ASL stimulate the translation of codon-biased transcripts.  
The translation of MoTTs is analogous to lock and key models of enzyme catalysis, in 
which specific structural fits are needed to meld the codon with the anticodon.  Average 
transcripts that do not contain specific codon biases do not need the extra-modified 
tRNA, as they are efficiently translated under all conditions.  In contrast, the translation 
of MoTTs in cells lacking tRNA modifications is severely reduced.  In essence, increased 
tRNA modification in response to stress is proposed to drive increased translation of 
stress response proteins. MoTTs have their translation tightly linked to tRNA 
modification systems,1 and are analogous to promoters that have been epigenetically 
 regulated by methylation signals, in that only some but not all transcripts are regulated in 
this way.   
MoTTs can be identified by their selective use of specific degenerate codons, 
and it should be noted that selective codon usage is a theme that carries over to another 
stress-related translational control mechanism, namely the recoding for selenocysteine 
incorporation into ROS detoxifying proteins.  Selenocysteine is considered the 21st 
amino acid for which there is no dedicated codon.  Rather, cells have expanded the 
genetic code by recoding internal UGA stop codons for the insertion of selenocysteine in 
a process that requires multiple factors, including specific SECIS signals in the 3’ UTR, 
accessory proteins, and specifically modified selenocystyl-tRNAs.13-15 Selenocysteine-
containing transcripts typically have at least two stop codons per transcript, which 
represents a significant codon bias that meets one of the MoTTs criteria.  As a second 
criterion, the specific selenocystyl-tRNA used to decode the UGA stop codon requires 
anticodon loop modifications (mcm5U34, mcm5Um34 and i6A37),13, 17, 18 further qualifying 
these stop codon enriched transcripts as MoTTs.  As the third and last criterion, many of 
the 25 identified selenoproteins in humans are predicted to function as stress response 
proteins, with GPXs and TrxRs well represented.15 With their biased codon use and 
requirement for tRNA modifications, in addition to encoding stress response proteins, the 
classification of selenocysteine transcripts as MoTTs offers another critical connection 
between translational regulation and the stress response.  Furthermore, it suggests that, 
similar to yeast systems, the corresponding tRNA modifications will be reprogrammed in 
response to stress. 
 
7.  Future outlook 
 The identification of stress-induced changes in tRNA modification, codon-biased 
translation, and MoTTs supports the idea that cells use distinct translational programs 
during stress responses.  In addition to our described LC-MS-based platform for 
detecting changes in stress-induced tRNA modifications that predict translation 
regulation, other technologies offer insight into regulation of translation elongation.  
Specifically, codon-biased translation can be quantified by codon-specific reporter 
systems, ribosome profiling, and proteomic analysis, with the last two dependent on 
corresponding bioinformatic analysis. Codon-specific reporters use Green Fluorescent 
Protein (GFP) or Luciferase readouts to link specific modification systems or stresses 
with the translation of codon runs.  While codon-specific reporters are typically used to 
analyze a subset of codons, codon reporter sets that address all 61 individual codons or 
the 3,904 combinations of two codons could be used to build a detailed picture of 
translation under specific stress-inducing conditions.  Similarly, the use of modification-
deficient cells in ribosome profiling provides a means to test the hypothesis that specific 
codons will be over- or under-represented in actively translated transcripts in tRNA 
modification mutants relative to wild-type cells.  Proteomics offers another path to 
quantifying changes in codon usage since a computational analysis of codon use in 
proteins up-regulated in stressed cells, after accounting for proteins whose levels 
correlate with transcriptional changes, reveals trends related to tRNA modifications 
reprogramming and translational regulation.  The combined use of ribosome profiling 
and proteomic analysis has the potential to identify significant codon bias in translated 
transcripts and up-regulated proteins.  As a corollary to translational up-regulation of 
stress response proteins, it is likely that stress-induced changes in tRNA modification will 
cause significant down-regulation in the translation groups of codon-biased transcripts, 
as an efficient means to shut down specific activities as the cell alters phenotype to 
 survive the stress.  Ongoing studies will test these models and other features of the 
translational control of cell stress response. 
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Figure Legends 
Figure 1.  Examples of tRNA modifications found in the ASL.  Enzyme-catalyzed 
modification of tRNA can promote anticodon-codon interactions, with modifications at 
positions 34 and 37 having mechanistic involvement in disease pathologies and stress 
signaling. 
 
Figure 2.  Alteration of tRNA structure promotes functional regulation. Regulation 
of tRNA transcription, processing and modification has been reported in response to 
many stresses, with each regulatory change having the potential to contribute to 
changes in global tRNA modification levels. Reprogramming of tRNA modifications has 
been linked to tumor suppression, mitochondrial diseases, cell cycle progression and 
DNA damage- and ROS-responses, among other stress response pathways. 
 
Figure 3.  A platform for systems-level quantification of stress-induced changes in 
tRNA modifications links them to regulation of specific genes based on codon 
usage.  The pipeline for identifying connections between specific tRNA modifications 
and codon-biased genes begins with (1) exposing cells to different stresses, (2) isolation 
and hydrolysis of tRNA, (3) HPLC resolution of individual ribonucleosides, followed by 
quantification of each ribonucleoside by mass spectrometry, (4) analysis of stress-
induced changes by multivariate statistical analysis, (5) assignment of significantly 
altered ribonucleosides to specific tRNAs, and (6) analysis of the cognate codons in 
 genome-wide, gene-specific methods to identify codon trends in stress-response 
transcripts. 
 
Figure 4. Model for the regulation of MoTTs and ordinary transcripts under normal 
and stress conditions.  Different stress conditions promote reprogramming of tRNA 
modifications that affects regular transcripts and MoTTs differentially.  Under normal 
conditions, both (A) regular transcripts that are not codon biased and (B) MoTTs are 
efficiently translated.  However, in response to stress-induced reprogramming of tRNA 
modifications, (C) MoTTs have their translation stimulated because the codon-bias 
(represented as indented stars) can be decoded by the stress-specific ASL modifications 
(green stars).  In the absence of modified tRNA (D), MoTTs are poorly translated and 
this leads to decreased levels of stress response proteins and sensitivity to the stress. 
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Figure 3. tRNA modification and codon bias analysis 
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